MA45177A - Traitement de la maladie de parkinson - Google Patents
Traitement de la maladie de parkinsonInfo
- Publication number
- MA45177A MA45177A MA045177A MA45177A MA45177A MA 45177 A MA45177 A MA 45177A MA 045177 A MA045177 A MA 045177A MA 45177 A MA45177 A MA 45177A MA 45177 A MA45177 A MA 45177A
- Authority
- MA
- Morocco
- Prior art keywords
- parkinson
- disease
- treatment
- Prior art date
Links
- 208000018737 Parkinson disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621019087 | 2016-06-02 | ||
| PCT/IN2017/050224 WO2017208267A1 (fr) | 2016-06-02 | 2017-06-02 | Traitement de la maladie de parkinson |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA45177A true MA45177A (fr) | 2019-04-10 |
| MA45177B1 MA45177B1 (fr) | 2022-08-31 |
Family
ID=83280007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA45177A MA45177B1 (fr) | 2016-06-02 | 2017-06-02 | Traitement de la maladie de parkinson |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA45177B1 (fr) |
-
2017
- 2017-06-02 MA MA45177A patent/MA45177B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA45177B1 (fr) | 2022-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3515505A4 (fr) | Traitement vaa de la maladie de huntington | |
| MA49402A (fr) | Polynucléotides aadc pour le traitement de la maladie de parkinson | |
| EP3645121A4 (fr) | Méthodes de traitement de la maladie de huntington | |
| EP3644996A4 (fr) | Procédés de traitement de la maladie de huntington | |
| MA41115A (fr) | Procédé de traitement de la maladie d'alzheimer | |
| EP3370721A4 (fr) | Traitement de l'ostéoarthrite | |
| EP3458589A4 (fr) | Compositions et méthodes de traitement de la maladie de huntington | |
| EP3490582A4 (fr) | Méthodes et compositions de traitement de maladie. | |
| EP3291815A4 (fr) | Méthodes de traitement d'une maladie neurodégénérative | |
| MA45149A (fr) | Méthodes de traitement de la maladie d'alzheimer | |
| EP3452166A4 (fr) | Stimulation intranasale pour le traitement de la maladie de la glande de meibomius et de la blépharite | |
| EP3528852A4 (fr) | Méthodes et compositions pour le traitement de la maladie de fabry | |
| HUE059387T2 (hu) | Parkinson-kór kezelése | |
| EP3294345A4 (fr) | Formulations de tpp1 et méthodes de traitement de la maladie cln2 | |
| EP2978446A4 (fr) | Procédés et agents pour le traitement de la maladie d'alzheimer | |
| EP3454793A4 (fr) | Bobines de traitement d'anévrisme | |
| MA46353A (fr) | Méthodes de traitement de l'infertilité féminine | |
| EP3833435A4 (fr) | Détermination de la maladie de parkinson | |
| EP3546449A4 (fr) | Dérivé de pipéridine -2,6-dicétone et traitement de la maladie de crohn | |
| EP3458062A4 (fr) | Traitement de la douleur | |
| EP3398614A4 (fr) | Agent pour la prévention et/ou le traitement de la maladie d'alzheimer | |
| MA41782A (fr) | Traitement de patients atteints de diabète de type 2 | |
| EP3628008A4 (fr) | Compositions et méthodes pour le traitement de la maladie d'alzheimer | |
| PT3458045T (pt) | Ebselen para uso no tratamento da doença de ménière | |
| SI3458067T1 (sl) | Zdravljenje nevroloških obolenj |